Alan Yueh-Luen Lee

12PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 23, 2025
Correction: Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface.

Ananth Ponneri Babuharisankar, Cheng-Liang Kuo, Han-Yu Chou

|Mar 17, 2023
Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface.

Ananth Ponneri Babuharisankar, Cheng-Liang Kuo, Han-Yu Chou

|Sep 26, 2022
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?

Cheng-Liang Kuo, Ananth Ponneri Babuharisankar, Ying-Chen Lin

|Jul 27, 2022
A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.

Cheng-Liang Kuo, Han-Yu Chou, Hui-Wen Lien

|Mar 17, 2022
Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells.

Vidhya Tangeda, Yu Kang Lo, Ananth Ponneri Babuharisankar

|Dec 16, 2020
Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells.

Semon Wu, I-Chieh Tseng, Wen-Cheng Huang

Pageof 2

Frequent Collaborators

2 joint publications

Tsung-Hsien Chuang

1 joint publications

Hsueh-Fen Juan

1 joint publications

Shih Sheng Jiang

1 joint publications

Chun-Hua Hsu